# Quality Control of CE-Certified Phonak Hearing Aids - 2017_37

> **NCT03379766** · NA · COMPLETED · sponsor: **Sonova AG** · enrollment: 20 (actual)

## Conditions studied

- Hearing Loss, Sensorineural

## Interventions

- **DEVICE:** Successor of Phonak Audéo B-Direct
- **DEVICE:** Phonak Audéo B-Direct

## Key facts

- **NCT ID:** NCT03379766
- **Lead sponsor:** Sonova AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-08
- **Primary completion:** 2018-02-02
- **Final completion:** 2018-02-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03379766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03379766, "Quality Control of CE-Certified Phonak Hearing Aids - 2017_37". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03379766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*